M&A Deal · 30 Apr 2026
Curaleaf
Acquirer · CURLF ▼ 3.2%
F2
Four 20 Pharma (remaining 45%)
Target
Undisclosed
Deal value
Minority Buyout
Type
EU
Region
Completed
Status
Announced
Completed
Completed buyout of the remaining 45% stake in Four 20 Pharma GmbH — a fully EU-GMP and GDP licensed German producer and distributor of medical cannabis. Strengthens Curaleaf's vertically integrated supply chain from Portugal/Canada cultivation through German distribution.
More deals by Curaleaf
Curaleaf → Northern Green Canada $16m
Acquisition · 2024
Curaleaf → Deseret Wellness ~$20m
Acquisition · 2023
Curaleaf → Grassroots Cannabis ~$700m
Acquisition · 2020
Curaleaf → Cura Partners (Select) Undisclosed
Acquisition · 2020